1. Home
  2. IXHL

as 12-18-2024 3:36pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Nasdaq

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Founded: 2001 Country:
Australia
Australia
Employees: N/A City: DOCKLANDS, VICTORIA
Market Cap: 39.2M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 16.6K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.39 EPS Growth: N/A
52 Week Low/High: $1.50 - $8.47 Next Earning Date: 11-14-2024
Revenue: $86,000 Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

IXHL Daily Stock ML Predictions

Share on Social Networks: